US 11,987,558 B1
ALK5 inhibitors and their uses
Dori A. Thomas-Karyat, Short Hills, NJ (US)
Assigned to Synthis Therapeutics, Inc., New York, NY (US)
Filed by Synthis Therapeutics, Inc., New York, NY (US)
Filed on Mar. 24, 2023, as Appl. No. 18/189,387.
Application 18/189,387 is a division of application No. 18/146,269, filed on Dec. 23, 2022.
Application 18/146,269 is a division of application No. 16/654,194, filed on Oct. 16, 2019, granted, now 11,583,593, issued on Feb. 21, 2023.
Application 16/654,194 is a continuation of application No. 16/286,122, filed on Feb. 26, 2019, abandoned.
Application 16/286,122 is a continuation of application No. 16/029,351, filed on Jul. 6, 2018, abandoned.
Application 16/029,351 is a continuation of application No. 15/404,233, filed on Jan. 12, 2017, abandoned.
Claims priority of provisional application 62/278,928, filed on Jan. 14, 2016.
This patent is subject to a terminal disclaimer.
Int. Cl. C07D 231/04 (2006.01)
CPC C07D 231/04 (2013.01) 2 Claims
 
1. A compound having the structure

OG Complex Work Unit Chemistry